LAURA MELARO: Open Payments
NPI 1750450649 · BOLIVAR, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182,243 in 324 payments from 8 companies in 2025. Trend: 2023 $177,394 · 2024 $165,396 · 2025 $182,243
Speaker / faculty: $111,695Consulting: $26,286Travel & lodging: $20,619Honoraria: $17,876Food & beverage: $5,768
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 141 | $72,567 |
| Neurocrine BioSciences, Inc. | 88 | $67,197 |
| Axsome Therapeutics, Inc. | 49 | $21,955 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 39 | $20,258 |
| Lundbeck LLC | 4 | $201 |
| Alkermes, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: INGREZZA, REXULTI, Auvelity, CAPLYTA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, ARISTADA, UZEDY.
Industry payments across TN — which companies pay providers there.
